Is TSBX or EQR a better dividend investment in 2026?

TSBX currently yields 563.38% with a 5% 5-year dividend growth rate. EQR yields 4.73% with 5% growth. The better choice depends on your goal: TSBX offers higher current income.

What is the dividend yield difference between TSBX and EQR?

TSBX has a forward dividend yield of 563.38% ($2.00/share annually). EQR yields 4.73% ($2.77/share annually). The yield gap is 558.65 percentage points.

Home › Compare › TSBX vs EQR

TSBX vs EQR: Dividend Comparison 2026

TSBX yields 563.38% · EQR yields 4.73%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 TSBX wins by $156404.01M in total portfolio value

INVESTMENT

TIME HORIZON10 years

TSBX

● Live price

563.38%

Share price

$0.36

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$156404.05M

Annual income

$115,926,179,183.70

Full TSBX calculator →

EQR

● Live price

4.73%

Share price

$58.58

Annual div

$2.77

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$40.5K

Annual income

$3,819.61

Full EQR calculator →

Portfolio growth — TSBX vs EQR

📍 TSBX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TSBX	EQR
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TSBX + EQR cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TSBX pays

EQR pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TSBX

Annual income on $10K today (after 15% tax)

$47,887.32/yr

After 10yr DRIP, annual income (after tax)

$98,537,252,306.14/yr

EQR

Annual income on $10K today (after 15% tax)

$401.93/yr

After 10yr DRIP, annual income (after tax)

$3,246.67/yr

At 15% tax rate, TSBX beats the other by $98,537,249,059.48/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TSBX + EQR for your $10,000?

TSBX: 50%EQR: 50%

100% EQR50/50100% TSBX

Portfolio after 10yr

$78202.05M

Annual income

$57,963,091,501.65/yr

Blended yield

74.12%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

TSBX

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$0.50

+40.8% upside vs current

Range: $0.50 — $0.50

Altman Z

-23.2

Piotroski

2/9

EQR

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$70.35

+20.1% upside vs current

Range: $63.00 — $78.50

Altman Z

1.8

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TSBX buys

EQR buys

No recent congressional trades found for TSBX or EQR in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTSBXEQR

Forward yield	563.38% ✓	4.73%
Annual dividend / share	$2.00	$2.77 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$156404.05M ✓	$40.5K
Annual income after 10y	$115,926,179,183.70 ✓	$3,819.61
Total dividends collected	$152979.84M ✓	$16.9K
Payment frequency	quarterly	quarterly
Sector	Stock	REIT
Analyst consensus	Buy	Hold
Analyst price target	$0.50	$70.35 ✓

Year-by-year: TSBX vs EQR ($10,000, DRIP)

Year	TSBX Portfolio	TSBX Income/yr	EQR Portfolio	EQR Income/yr	Gap
1← crossover	$67,038	$56,338.03	$11,248	$547.57	+$55.8K → TSBX
2	$424,702	$352,971.06	$12,701	$666.53	+$412.0K → TSBX
3	$2,544,295	$2,089,864.53	$14,405	$814.59	+$2.53M → TSBX
4	$14,423,258	$11,700,861.61	$16,413	$999.84	+$14.41M → TSBX
5	$77,424,065	$61,991,178.81	$18,795	$1,232.92	+$77.41M → TSBX
6	$393,842,555	$310,998,805.50	$21,639	$1,527.95	+$393.82M → TSBX
7	$1,899,912,512	$1,478,500,978.24	$25,057	$1,903.80	+$1899.89M → TSBX
8	$8,698,653,014	$6,665,746,626.53	$29,197	$2,385.87	+$8698.62M → TSBX
9	$37,829,785,494	$28,522,226,769.44	$34,250	$3,008.70	+$37829.75M → TSBX
10	$156,404,049,663	$115,926,179,183.70	$40,467	$3,819.61	+$156404.01M → TSBX

TSBX vs EQR: Complete Analysis 2026

TSBX — Stock

Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, and uveal melanoma, as well as an investigator sponsored trial to treat cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. The company was founded in 2014 and is based in LA Jolla, California.

Full TSBX Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →

📬

Get this TSBX vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TSBX vs SCHD TSBX vs JEPI TSBX vs O TSBX vs KO TSBX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.